What is the 13F Pro Quality Score for UHS?

13F Pro ranks UNIVERSAL HEALTH SERVICES INC (UHS) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View UHS's current score at https://13fpro.ai/research/UHS (free sign-up required for the full ranking).

Where does 13F Pro source UHS data?

All UNIVERSAL HEALTH SERVICES INC fundamentals and ownership data come directly from SEC EDGAR. UNIVERSAL HEALTH SERVICES INC files with the SEC under CIK 352915. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is UHS in?

UNIVERSAL HEALTH SERVICES INC (UHS) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

What drives UHS's revenue?

Per UNIVERSAL HEALTH SERVICES INC's latest 10-Q filed with the SEC on 2026-05-07, the biggest revenue drivers are: Acute Care Hospital Services ($2.610B, +10.7% YoY); Behavioral Health Care Services ($1.882B, +8.2% YoY); Other non-segment revenue ($2.9M). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/research/UHS.

What are UHS's largest expenses?

UNIVERSAL HEALTH SERVICES INC's latest 10-Q reports these as the largest expense items: Salaries, wages and benefits ($2.088B, +6.7% YoY); Supplies expense ($427M, +6.0% YoY). Sourced directly from SEC EDGAR filing text for Q1 2026 (quarter ended March 31, 2026).

How often is UHS research updated on 13F Pro?

UHS's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

UNIVERSAL HEALTH SERVICES INC(UHS)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSE

Institutional-grade research for retail investors

SEC EDGAR: CIK 352915 UHS stock profile & AI dashboard →

13F Pro Quality Score

71.2/100

Rank #272 of 2,879 stocksTOP 10%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

64.6/100

Profitability

66.5/100

Balance Sheet

84.7/100

Earnings Quality

79.2/100

Free Cash Flow

48.4/100

Institutional Flow

73.2/100

Revenue Scale

91.9/100

Dilution Risk

72.9/100

UHS Stock Analysis & AI Quality Score

AI stock analysis and institutional research for UNIVERSAL HEALTH SERVICES INC (UHS), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores UHS at 71.2/100 on a 32-signal composite quality model, placing it at rank #272 of 2,879 stocks — the top 10% of the AI-ranked universe. UHS scores in the top quartile across revenue scale (91.9), balance sheet strength (84.7), earnings quality (79.2). Based on the latest XBRL financial filings (Q1 2026), UNIVERSAL HEALTH SERVICES INC reports quarterly revenue of $4.5B, net income of $348.7M, an operating margin of 11.2%. Top institutional holders of UHS by reported 13-F value include First Eagle Investment Management,, BlackRock,, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. UHS trades on the NYSE exchange and files with the SEC under CIK 352915. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate UHS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for UNIVERSAL HEALTH SERVICES INC directly from SEC EDGAR. UNIVERSAL HEALTH SERVICES INC's 13F Pro composite quality score has ranged between 8 and 72 since 2021, currently 71.2 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.

✦

Fun facts about UNIVERSAL HEALTH SERVICES INC

Quirks, history, and lore behind UHS — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. healthcare services company · large-cap · listed on NYSE · headquartered in Pennsylvania.
2
The Numbers
Operates roughly 400 facilities across the country and generates annual revenue of around $14 billion — making it one of the largest for-profit hospital operators in America.
3
The History
Founded in 1979, it grew through decades of acquisitions into a sprawling network of acute care hospitals, behavioral health facilities, and outpatient centers.
4
The Secret
Its lesser-known specialty is actually its behavioral health division, which runs hundreds of psychiatric and substance-abuse treatment facilities — a bigger footprint than most people realize.
5
The Lore
The company has weathered significant scrutiny over its psychiatric care practices, including government investigations, yet remains a dominant player in an industry with very high barriers to entry.
6
The Giveaway
Its ticker is three letters that also happen to be a common abbreviation for a hospital system, and its full name starts with a word you'd expect on a movie studio, not a hospital chain.

▶ Think you know your stocks? Play the Daily Ticker

What's Driving UHS's Business? Latest 10-Q Breakdown

AI-extracted from UNIVERSAL HEALTH SERVICES INC's 10-Q filed 2026-05-07 — Q1 2026 (quarter ended March 31, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Net revenues grew 9.6% to $4.5B; net income attributable to UHS rose 10% to $349M, driven by 8% growth in acute care and behavioral health same-facility revenues.

Biggest Revenue Drivers

Total revenue: $4.495B+9.6% YoY

Acute Care Hospital Services$2.610B+10.7% YoY

Same-facility revenues increased 8.2%; net revenue per adjusted admission rose 6.3%.

Behavioral Health Care Services$1.882B+8.2% YoY

Same-facility revenues increased 7.3%; patient days increased 1.4%; net revenue per adjusted admission rose 6.2%.

Other non-segment revenue$2.9M

Includes advisory fees and other ancillary revenues.

Largest Expense Items

Salaries, wages and benefits$2.088B+6.7% YoY

Increase driven by higher staffing levels and wage pressures in acute care and behavioral health segments.

Supplies expense$427M+6.0% YoY

Increase reflects higher supply costs across acute care and behavioral health operations.

Margins: Operating margin expanded slightly to 11.2% from 11.1% YoY, benefiting from improved same-facility operating leverage and revenue per adjusted admission gains. Income before taxes margin was 10.4% versus 10.3% YoY, stable despite inflationary cost pressures.

Watch Items from the Filing

One Big Beautiful Bill Act enacted July 4, 2025 will reduce aggregate annual net benefit from Medicaid supplemental payments by $432M–$480M by 2032 through SDP rate caps and provider tax reductions.
Laurel Ridge Treatment Center terminated from Medicare/Medicaid effective April 30, 2026; facility generated ~$23M pre-tax income in FY2025; operating losses expected during reapplication process.
Pinnacle Medical Group litigation verdict of $4.7M compensatory + $500M punitive (reduced to ~$14M under Nevada law); post-trial motions pending; new trial ordered due to juror misconduct; $18M reserve recorded.
$700M of 1.65% senior notes due September 2026 will be refinanced at significantly higher rates, materially increasing annual interest expense.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q1 2026

$4.5B

Net Income

Q1 2026

$348.7M

Free Cash Flow

Q1 2026

$184.5M

Operating Margin

Q1 2026

11.2%

D/E Ratio

Q1 2026

0.73

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+9.7% YoY

$17.36BFY 2025

FY22 $13.40BFY23 $14.28BFY24 $15.83BFY25 $17.36B

Net Income

+30.4% YoY

$1.49BFY 2025

FY22 $675.6MFY23 $717.8MFY24 $1.14BFY25 $1.49B

Operating Income

+18.6% YoY

$1.99BFY 2025

FY22 $1.00BFY23 $1.18BFY24 $1.68BFY25 $1.99B

EPS (Diluted)

+37.3% YoY

$23.10FY 2025

FY22 $9.14FY23 $10.23FY24 $16.82FY25 $23.10

Total Assets

+7.3% YoY

$15.53BFY 2025

FY22 $13.49BFY23 $13.97BFY24 $14.47BFY25 $15.53B

Total Debt

+22.2% YoY

$5.55BFY 2025

FY22 $4.89BFY23 $5.04BFY24 $4.54BFY25 $5.55B

Op. Cash Flow

-9.8% YoY

$1.86BFY 2025

FY22 $996.0MFY23 $1.27BFY24 $2.07BFY25 $1.86B

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019
Revenue	$17.36B +9.7%	$15.83B +10.8%	$14.28B +6.6%	$13.40B +15.9%	$11.56B +1.6%	$11.38B
Net Income	$1.49B +30.4%	$1.14B +59.1%	$717.8M +6.2%	$675.6M -28.4%	$944.0M +15.8%	$814.9M
Operating Income	$1.99B +18.6%	$1.68B +43.1%	$1.18B +17.1%	$1.00B -26.1%	$1.36B +11.7%	$1.22B
EPS (Diluted)	$23.10 +37.3%	$16.82 +64.4%	$10.23 +11.9%	$9.14 -16.8%	$10.99 +20.4%	$9.13
Total Assets	$15.53B +7.3%	$14.47B +3.6%	$13.97B +3.5%	$13.49B +0.1%	$13.48B +15.5%	$11.67B
Total Debt	$5.55B +22.2%	$4.54B -9.9%	$5.04B +3.1%	$4.89B +15.5%	$4.23B +3.9%	$4.07B
Operating Cash Flow	$1.86B -9.8%	$2.07B +63.0%	$1.27B +27.3%	$996.0M -57.8%	$2.36B +64.1%	$1.44B

AI Insight: UHS Financial Trends

UHS delivers consistent revenue and earnings growth over eight quarters, but a sharp debt jump in Q3 2025 warrants monitoring.

• Revenue grew steadily from $3,908M in Q2 2024 to $4,495M in Q1 2026, a ~15% increase over eight quarters.

• Operating income expanded from $436M in Q2 2024 to $503M in Q1 2026, with operating margin broadly holding above 11%.

• Net income rose from $289M in Q2 2024 to $349M in Q1 2026, with a peak of $446M in Q4 2025.

• Equity grew steadily from $6,485M in Q2 2024 to $7,465M in Q1 2026, suggesting retained earnings accumulation.

⚠ Total debt jumped from $4,650M in Q1 2025 to $5,440M in Q3 2025 — a $790M spike — and remains elevated at $5,456M in Q1 2026.

⚠ Operating cash flow is volatile, ranging from $333M to $679M; Q1 2026 Op CF of $402M lags net income conversion.

AI Insight: UHS Ratio Trends

UHS profitability is broadly stable year-over-year, but Q4 2025's outsized 9.9% NPM and 24.5% ROE appear driven by a one-time item that reverses sharply in Q1 2026.

• Operating margin held in a tight 11.1%–11.7% band from Q1 2025 through Q1 2026, signaling consistent core earnings power.

• ROE recovered from a trough of 15.7% in Q3 2024 to 20.1% in Q2 2025, reflecting genuine underlying improvement before Q4 2025 spike.

• D/E leverage ticked up to 0.76 in Q3–Q4 2025 from 0.66 in Q2 2025, then eased slightly to 0.73 in Q1 2026.

⚠ Q4 2025 NPM surged to 9.9% vs. the 7.4%–8.3% range in prior quarters — identify the one-off driver before extrapolating.

⚠ ROIC slipped to 15.6% in Q1 2026, the lowest since Q3 2024's 13.6% trough — watch for further deterioration.

⚠ D/E at 0.73 remains above the Q2 2025 low of 0.66; rising leverage alongside softer ROIC warrants monitoring.

Get alerted when UHS's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for UNIVERSAL HEALTH SERVICES INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of UHS

First Eagle Investment Management, LLC
$791.8M4,424,281 sh
BlackRock, Inc.
$777.6M4,345,083 sh
VANGUARD CAPITAL MANAGEMENT LLC
$618.0M3,452,885 sh
STATE STREET CORP
$461.6M2,579,389 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$448.9M2,508,167 sh
GEODE CAPITAL MANAGEMENT, LLC
$347.6M1,947,868 sh
PZENA INVESTMENT MANAGEMENT LLC
$342.2M1,912,235 sh
DIMENSIONAL FUND ADVISORS LP
$318.8M1,781,262 sh
Invesco Ltd.
$284.4M1,589,120 sh
GOLDMAN SACHS GROUP INC
$238.2M1,330,971 sh

Fund	Value	Shares
First Eagle Investment Management, LLC	$791.8M	4,424,281
BlackRock, Inc.	$777.6M	4,345,083
VANGUARD CAPITAL MANAGEMENT LLC	$618.0M	3,452,885
STATE STREET CORP	$461.6M	2,579,389
VANGUARD PORTFOLIO MANAGEMENT LLC	$448.9M	2,508,167
GEODE CAPITAL MANAGEMENT, LLC	$347.6M	1,947,868
PZENA INVESTMENT MANAGEMENT LLC	$342.2M	1,912,235
DIMENSIONAL FUND ADVISORS LP	$318.8M	1,781,262
Invesco Ltd.	$284.4M	1,589,120
GOLDMAN SACHS GROUP INC	$238.2M	1,330,971

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put UHS on your watchlist

Track score changes the day UNIVERSAL HEALTH SERVICES INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is UHS a good stock to buy?

13F Pro's AI-powered analysis of UNIVERSAL HEALTH SERVICES INC (UHS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for UHS are available on the UHS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own UHS?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling UHS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of UNIVERSAL HEALTH SERVICES INC's investment landscape.